Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





4 subtopics

 

  • Adjuvants, Immunologic
  • Agglutinins
  • Immunosuppressive Agents
  • Interferon Inducers

Immunologic FactorsFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Chemical Actions and Uses > Pharmacologic Actions > Physiological Effects of Drugs > Immunologic Factors

Latest papers

Denosumab: new horizons in the treatment of osteoporosis. LID - 10.1111/j.1751-486X.2011.01641.x [doi]

Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).

Idiopathic thrombocytopenic purpura: advances in management.

Indications and safety of intravenous and subcutaneous immunoglobulin therapy.

[Rationale and clinical evidence for the use of rituximab in glomerular diseases].

Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice.

Unresolved issues in biologic therapy for rheumatoid arthritis.

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.

Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.

Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.

Proceedings of the XIIth International Symposium on Advances in Targeted Therapies. April 14-18, 2010.

[Risk of affective disorder in multiple sclerosis].

Sex steroids in autoimmune diseases.

DRACMA one year after: which changes have occurred in diagnosis and treatment of CMA in Italy?

[Methodic approaches to treatment of the chronic generalized parodontitis in elderly and senile patients].

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.

Sex steroids in autoimmune diseases.

[Immunomodulating effect of cyclophosphamide on cytotoxic activity of rats and mice splenocytes].

[Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulematosis patients with renal impairment].

Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.

page 1 2 3 4 5 6 7 8 9 10 11 ...